NCT03740386View on ClinicalTrials.gov

Phentolamine Mesylate as a Reversal of Local Anesthesics

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

November 9, 2018

Study Completion Date

November 9, 2018

Conditions
Anesthesia, Local
Interventions
DRUG

Phentolamine Mesylate 0.235 MG/ML [OraVerse]

compare effect of phentolamine mesylate in three arms

All Listed Sponsors
lead

León Formación

OTHER

NCT03740386 - Phentolamine Mesylate as a Reversal of Local Anesthesics | Biotech Hunter | Biotech Hunter